Commentary on Cohen et al.: Role of Clinical Factors in Precision Medicine Test to Predict Nonresponse to TNFi Therapies in Rheumatoid Arthritis

A 2021 study described the development and validation of a blood-based precision medicine test called the molecular signature response classifier (MSRC) that uses 23 features to identify rheumatoid arthritis (RA) patients who are likely nonresponders to tumor necrosis factor-α inhibitor (TNFi) thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Stanley, Curtis, Jeffrey R., Mellors, Theodore, Zhang, Lixia, Withers, Johanna B., Jones, Alex, Ghiassian, Susan D., Akmaev, Viatcheslav R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931968/
https://www.ncbi.nlm.nih.gov/pubmed/36441482
http://dx.doi.org/10.1007/s40744-022-00506-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931968/
https://www.ncbi.nlm.nih.gov/pubmed/36441482
http://dx.doi.org/10.1007/s40744-022-00506-0

Ejemplares similares